This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through September 7, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
large-cap: Archive
Buy Dell Technologies Stock Before Q2 Earnings as AI Server Demand Soars?
by Shaun Pruitt
Dell Technologies (DELL) is set to report Q2 results after-market hours on Tuesday, Sept. 1, with expectations running high following explosive growth in its AI infrastructure business.
DELLNegative Net Change AMDPositive Net Change NVDAPositive Net Change SMCINegative Net Change LNVGYNegative Net Change HPENegative Net Change
artificial-intelligence computers datacenter earnings investing large-cap tech-stocks
Salesforce (CRM) Stock Soars on Q2 Earnings: Is It Too Late to Buy?
by Shaun Pruitt
The surge in Salesforce (CRM) stock reflects renewed confidence that the company can turn artificial intelligence into a growth catalyst rather than be disrupted by AI.
CRMPositive Net Change CSCONegative Net Change DELLNegative Net Change UBERNegative Net Change HOODPositive Net Change
artificial-intelligence earnings internet investing large-cap software
CrowdStrike vs. Okta: Which Cybersecurity Stock Is the Better Buy After Q2 Earnings?
by Shaun Pruitt
Cybersecurity stocks surged on Thursday after CrowdStrike (CRWD) and Okta (OKTA) both topped Q2 expectations yesterday evening and raised their outlooks.
OKTANegative Net Change CRWDNegative Net Change FTNTNegative Net Change PANWNegative Net Change ZSPositive Net Change
artificial-intelligence cybersecurity earnings investing large-cap tech-stocks
Nvidia Stock Soars After Q2 Earnings: Is NVDA Still a Buy?
by Shaun Pruitt
Nvidia stock has surged more than 7% on Thursday after the AI chip giant delivered another blockbuster quarterly report yesterday evening.
NVDAPositive Net Change GSNegative Net Change BXNegative Net Change BLKNegative Net Change KKRNegative Net Change BAMNegative Net Change APONegative Net Change
artificial-intelligence datacenter earnings investing large-cap semiconductor tech-stocks
Is Abercrombie & Fitch (ANF) Stock Still a Buy After Its Q2 Surge?
by Shaun Pruitt
Abercrombie & Fitch (ANF) shares have surged over 30% on Wednesday after reporting stronger-than-expected Q2 results this morning and a substantial increase in full-year guidance.
ANFPositive Net Change
apparel earnings investing large-cap
Is Marvell (MRVL) Stock Poised for Another AI-Fueled Rally as Q2 Earnings Approach?
by Shaun Pruitt
Outside of Nvidia, Marvell Technology will provide the semiconductor market's most closely watched earnings report this week on Thursday, August 27.
MRVLPositive Net Change AMZNNegative Net Change AMDPositive Net Change MSFTPositive Net Change NVDAPositive Net Change AVGOPositive Net Change GOOGLPositive Net Change ALABPositive Net Change
artificial-intelligence datacenter earnings electronics investing large-cap semiconductor tech-stocks
Is Nvidia (NVDA) Stock a Buy Ahead of Q2 Earnings?
by Shaun Pruitt
Nvidia will step back into the earnings spotlight after the market closes on Wednesday, August 26, when the AI chip leader reports its much-anticipated Q2 results.
NVDAPositive Net Change BACNegative Net Change MSFTPositive Net Change ORCLPositive Net Change GOOGLPositive Net Change NBISNegative Net Change CRWVNegative Net Change
artificial-intelligence earnings investing large-cap magnificent-7 semiconductor tech-stocks
Target vs. Walmart: Which Retail Stock Is the Better Buy After Q2 Earnings?
by Shaun Pruitt
Retail giants Target (TGT) and Walmart (WMT) both topped Q2 earnings expectations this week and raised their full-year outlooks, but investors reacted very differently.
TGTNegative Net Change WMTNegative Net Change
dividend-investing dividends earnings investing large-cap retail
Moderna or Merck: Which Soaring Cancer Vaccine Stock Is the Better Buy?
by Shaun Pruitt
Shares of Moderna (MRNA) and Merck (MRK) are soaring Wednesday after the companies reported a potentially historic breakthrough for their personalized mRNA cancer vaccine.
MRKNegative Net Change MRNAPositive Net Change
biotechnology cancer cell-therapy dividends genetics hospitals immuno-therapy investing large-cap medical pharmaceuticals
Bear of the Day: Coinbase Global (COIN)
by Shaun Pruitt
While Coinbase's (COIN) long-term story may remain intriguing, the near-term earnings picture has deteriorated considerably.
COINPositive Net Change
cryptocurrency earnings finance investing large-cap